Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Fiala

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2020
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US StudyAmber Afzal, Mark A Fiala, Brian F Gage, et al.
Transfusion|June 18, 2016
Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantationMark A Fiala, Soo Park, Michael Slade, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2023
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic ReviewHamlet Gasoyan, Mark A Fiala, Michelle Doering, et al.
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
Blood Cancer Journal|May 10, 2023
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort studyHira Mian, Tanya M Wildes, Ravi Vij, et al.
JCO Clinical Cancer Informatics|December 15, 2018
Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data SetsMark A Fiala, James Dukeman, Sascha A Tuchman, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2025
Financial Toxicity and Satisfaction With Cancer Treatment Among Patients With Multiple Myeloma: An Analysis of the MMRF's CureCloud InitiativeMark A Fiala, Eva Lepisto, Chioma Amadi-Mgbenka, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2023
The Dynamics of Financial Toxicity in Multiple MyelomaMark A Fiala, Alice E Silberstein, Mark A Schroeder, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Journal of Geriatric Oncology|June 1, 2023
Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancerEkamjit S Deol, Kristen M Sanfilippo, Suhong Luo, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2020
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US StudyAmber Afzal, Mark A Fiala, Brian F Gage, et al.
Transfusion|June 18, 2016
Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantationMark A Fiala, Soo Park, Michael Slade, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2023
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic ReviewHamlet Gasoyan, Mark A Fiala, Michelle Doering, et al.
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
Blood Cancer Journal|May 10, 2023
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort studyHira Mian, Tanya M Wildes, Ravi Vij, et al.
JCO Clinical Cancer Informatics|December 15, 2018
Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data SetsMark A Fiala, James Dukeman, Sascha A Tuchman, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 3, 2025
Financial Toxicity and Satisfaction With Cancer Treatment Among Patients With Multiple Myeloma: An Analysis of the MMRF's CureCloud InitiativeMark A Fiala, Eva Lepisto, Chioma Amadi-Mgbenka, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2023
The Dynamics of Financial Toxicity in Multiple MyelomaMark A Fiala, Alice E Silberstein, Mark A Schroeder, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2019
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible MechanismsScott R Goldsmith, Mark A Fiala, Julie O'Neal, et al.
Journal of Geriatric Oncology|June 1, 2023
Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancerEkamjit S Deol, Kristen M Sanfilippo, Suhong Luo, et al.
Pageof 8